Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Instil Bio Inc TIL

Instil Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of novel therapies. The Company seeks to in-license/acquire and develop novel therapeutic candidates in diseases with significant unmet medical need. Its first such program is an engineered tumor infiltrating lymphocyte (TIL), cell therapy for the treatment of cancer. It is engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor (CoStAR), platform. The Company's lead CoStAR-TIL product candidate, ITIL-306, expresses a CoStAR molecule designed to recognize folate receptor alpha (Fra), a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC and renal cancer. CAR-T and TCR-T therapies are cell products composed of T cells that have been genetically engineered to recognize a specific cancer-related antigen on the surface of tumor cells.


NDAQ:TIL - Post by User

Bullboard Posts
Comment by kaosblueson Feb 15, 2012 12:40pm
432 Views
Post# 19537892

RE: RE: RE: RE: RE: NI43-101 UPDATE?

RE: RE: RE: RE: RE: NI43-101 UPDATE?

Thanks for the info Litex.  This confirms almost exactly what I had noted the other day. I was pretty sure that good news was coming and regardless of all the nervous nellies out there, I will go on record now , as opposed to a couple of years from now, that this is a brilliant move by Bill Sherrif.  He has put virtually all of the other projects on hold or on slow down and is concentrating most of the resources of the company on the developemnt of Brewery Creek.  Now seriously folks, would you rather have 75% of that deal or 100?  I realize there is a small amount of dilution here but in my opinion the increase is easily justified and in short order many of you will be jumping on the bandwagon after coming to the realization that this is the way to "grow" a company. I'm not too worried about the market for the short term here, what I believe is that we will see a substantial jump on the publication of the NR 43's. Good management and smart moves make for a strong SP even if it does often take some time for the market to get it. I am absolutely in line with your thinking on this Scottie as will most of this Board be in a couple of months time.

Bullboard Posts